Clinical Study
Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy
Table 1
Baseline characteristics of women by study group.
| | Group | | Measurements | Placebo (n=19) | Inulin (n=19) | p |
| Age (years) | 51.89 (10.36) | 51.58 (8.45) | 0.919 | Weight (kg) | 61.97 (10.90) | 69.16 (13.77) | 0.083 | Fasting glucose | | | | Normal | 11 (28.9) | 4 (10.5) | 0.045 | High | 8 (21.1) | 15 (39.5) | Creatinine clearance | | | | Low | 8 (21.1) | 7 (18.4) | 0.999 | Normal | 11 (28.9) | 12 (31.6) | Menopause | | | | Premenopause | 9 (23.7) | 7 (18.4) | 0.743 | Postmenopause | 10 (26.3) | 12 (31.6) | Chronic medication | | | | Yes | 7 (18.4) | 12 (31.6) | 0.194 | No | 12 (31.6) | 7 (18.4) | HTA medication | | | | Yes | 4 (10.5) | 10 (26.3) | 0.091 | No | 15 (39.5) | 9 (23.7) | |
|
|
Data: media (standard deviation); Student’s t-test: p<0.05. n (%), test: p<0.05. Fasting glucose: normal ≤99 mg/dl; high ≥100 mg/dl. Creatinine clearance: normal ≥90 ml/min; low ≤89 ml/min. HTA: hypertension. |